Psychiatry & Neurology Doctors in Bristol, CT Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Frederick O Reindel, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 10 N Main St Ste 210, Bristol, CT 06010 Phone: 860-314-2052    Fax: 860-314-2054

Alexander Komm, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 975 Farmington Ave, Bristol, CT 06010 Phone: 860-582-4197

Dr. Jeffrey T Shelton, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 440 N Main St Ste C, Upper Level, Bristol, CT 06010 Phone: 860-583-5858    Fax: 860-584-9962

Manoharan Nachiyappan, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 10 N Main St Ste 210, Bristol, CT 06010 Phone: 860-314-2052    Fax: 860-314-2054

Cara Pittari, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 25 Newell Rd Ste D21, Bristol, CT 06010 Phone: 860-585-9473

Dr. Genevieve Armstrong Henry, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 41 Brewster Rd, Bristol, CT 06010 Phone: 860-585-3122

News Archive

Cytta completes first client deployment of remote medical monitoring system

Cytta Corp is pleased to announce that we have now successfully completed the first client installation and deployment of our remote medical monitoring system. This installation enables the Company to commence a full scale roll out of its technology, concentrating initially on our clients consisting of payors and providers, such as: Health Plans, Managed Care Organizations, Health Delivery Organizations, Medical Groups and IPAs, located in the Southern California area.

UAB School of Nursing offers health care services in rural communities

"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.

Natalizumab returns to market

Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).

New entitlement is not a viable health care reform, says Concord Coalition

As House and Senate leaders negotiate the final details of their respective health care reforms bills, The Concord Coalition warned today that one provision under consideration, the Community Living Assistance Services and Supports (CLASS) Act, is structurally unsound and fiscally irresponsible.

A man's height linked to prostate cancer development and progression

A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies.

Read more Medical News

› Verified 1 days ago